A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DMC / data monitoring committee

[Related PubMed/MEDLINE]
Total Number of Papers: 42
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DMC  (>> Co-occurring Abbreviation)
Long Form:   data monitoring committee
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 High-flow versus standard nasal cannula in morbidly obese patients during colonoscopy: A prospective, randomized clinical trial. HFNC, LPM, SNC
2017 'We all want to succeed, but we've also got to be realistic about what is happening': an ethnographic study of relationships in trial oversight and their impact. TMG, TSC
2017 A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials. RCTs, TSC
2017 Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial. PFS
2016 Responsibilities of Data Monitoring Committees: Consensus Recommendations. ---
2015 An Estimate of the Benefit-Cost Impact of the FDA Guidance on Data Monitoring Committees. ---
2015 DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60years with acute myeloid leukemia who are ineligible for induction chemotherapy. AML, ATRA, CR, DAC, EU, HDAC, PR, VPA
2015 Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial. AIS, DHI
2015 Exploring the role and function of trial steering committees: results of an expert panel meeting. MRC, PPI, TSC
10  2014 A Practical Guide to Data Monitoring Committees in Adaptive Trials. ---
11  2014 Bayesian stopping guidelines for heart valve premarket approval studies. OPC, PMA
12  2014 Establishing a data monitoring committee for clinical trials. ---
13  2014 Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT. CO, CONcePT, HR, IO, TTF, TTP
14  2014 Initiating change locally in bullying and aggression through the school environment (INCLUSIVE): study protocol for a cluster randomised controlled trial. ESYTC, GBS
15  2012 On the independence of data monitoring committee in adaptive design clinical trials. FDA
16  2011 Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. PAD, PDE
17  2011 Prematurely ended phase III trials in Sweden during the years 2002-2008. CTs
18  2010 Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. AEDs, AEs, i.v
19  2010 Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer. ABC, AEs, PFS
20  2009 A multi-centre randomised controlled study of pre-IVF outpatient hysteroscopy in women with recurrent IVF implantation failure: Trial of Outpatient Hysteroscopy - [TROPHY] in IVF. ---
21  2009 A web-based endpoint adjudication system for interim analyses in clinical trials. EAC, WebEAS
22  2009 Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis. EAC
23  2008 Enhancing communication among data monitoring committees and institutional review boards. IRB
24  2008 [Data monitoring committees. Third pillar in the methodical conduct of clinical trials]. ---
25  2008 [Monitoring the safety of participants in randomised clinical trials: basis and methods]. METC
26  2007 A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome. ---
27  2007 Should data monitoring committees assess efficacy when considering safety in trials in acute stroke? ---
28  2006 Futility approaches to interim monitoring by data monitoring committees. ---
29  2006 Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees. ---
30  2004 A major trial needs three statisticians: why, how and who? ---
31  2004 Issues in regulatory guidelines for data monitoring committees. FDA
32  2004 Liability issues for data monitoring committee members. ---
33  2004 Pharmacoepidemiology 101: data monitoring committees in the post-marketing approval setting. ---
34  2004 Playing safe and preserving integrity: making the FDA model work. ---
35  2004 Strength of accumulating evidence and data monitoring committee decision making. ---
36  2003 Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. CRO, MTD, NSCLC
37  2003 Termination of a randomized controlled trial of two vasectomy techniques. FHI, FI, HR
38  2002 Monitoring clinical trials: issues and controversies regarding confidentiality. ---
39  2001 Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial. DCLHb, FDA
40  1993 Data monitoring committees and capturing relevant information of high quality. ---
41  1993 Monitoring clinical trials: experience of, and proposals under consideration by, the Cancer Therapy Committee of the British Medical Research Council. CTC
42  1993 Use of spending functions for occasional or continuous monitoring of data in clinical trials. ---